-
Highlighting the DREAM Program for Late-Stage Lung Cancer Treatment
24 May 2025 01:40 GMT
… initial diagnosis of stage III lung cancer and subsequent treatments. Despite initial … to patients with stage IV lung cancer who have exhausted other treatment … using various methods, including advanced genetic testing of the removed tumor …
-
Mythic Therapeutics to Present Compelling Efficacy Data from Phase 1 KisMET-01 Study Supporting Best-in-Class Potential of Investigational cMET ADC, MYTX-011, in Non-Small Cell Lung Cancer
22 May 2025 21:03 GMT
… patients with non-small cell lung cancer (NSCLC) at the 2025 American … cMET levels, histologies, and actionable genetic alterations.
Details of the presentation …
Format: Poster Session
Session Name: Lung Cancer – Non-Small Cell Metastatic
Session …
-
He lost his mother, sisters, and brother to cancer. It was in their genes.
23 May 2025 16:37 GMT
… was a deadly cancer gene.
Science on the genetic roots of cancer … 1987, my sister, Gina, got lung cancer and died about six or … was 46 years old, developed lung cancer. Again, he was given a … she learned that she had lung cancer until just before she died …
-
NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer
22 May 2025 11:20 GMT
… with advanced non-small cell lung cancer (NSCLC) with a … testing is critical in lung cancer, where targeted therapies can … company specializing in cancer genetics testing and information services. … Protein-Expressing Non-Small-Cell Lung Cancer. J Clin Oncol. …
-
FOXP4 gene variants reveal new genetic link to long COVID risk
23 May 2025 04:28 GMT
… subclassified into ‘population controls’ (all genetic ancestry-matched participants without long … meta-analyses identified genetic variants of the FOXP4 gene as significant risk … of FOXP4 (a gene also linked to lung cancer and severe COVID-19 …
-
Gene Solutions introduces AI-powered blood test for lung cancer detection in Asia
21 May 2025 10:53 GMT
Gene Solutions introduces AI-powered blood test for lung cancer … shutterstock
Vietnam headquartered Gene Solutions has introduced SPOT … of lung cancer, accounting for 62% of global lung cancer deaths. … multiple cancers, including lung cancer, in a single …
-
Seven lung cancer companies advancing new treatments in 2025
20 May 2025 13:28 GMT
… kinase (HSV-tk) gene to a patient’s … EGFR ex20ins inhibitor
Lead lung cancer candidate: Zipalertinib
Recent news … , Jazz Pharmaceuticals’ lead lung cancer drug is called Zepzelca … in settings outside of lung cancer.
Lung cancer treatment market expected to …
-
LIfT BioSciences presents preclinical data on its first-in-class Immunomodulatory Alpha Neutrophils at American Society of Gene & Cell Therapy 28th Annual Meeting, showcasing its versatility in diseases beyond oncology
22 May 2025 06:00 GMT
… at the American Society of Gene & Cell Therapy (ASGCT) 28th … , pancreatic and non-small cell lung cancer, IMANs drove substantial tumour cell … ), a proprietary enhancement media and genetic engineering. The company is preparing …
-
Proteomic Characterization of Extracellular Vesicles from Human Neural Precursor Cells: A Promising Advanced Therapy for Neurodegenerative Diseases
24 May 2025 12:50 GMT
… all amplified genes. Amplification of a constitutive gene, in this … without chemical inducers or gene transfections. This differentiation is … such as identifying the genetic material present in these … novel serodiagnostic marker for lung cancer. Am J Pathol. …
-
Geriatric Nutritional Risk Index (GNRI) and Prognostic Nutritional Index (PNI) Before Treatment as the Predictive Indicators for Bone Metastasis in Prostate Cancer Patients
24 May 2025 12:50 GMT
… tumor microenvironment, affecting gene homeostasis, inducing tumor … A. Prostate cancer review: genetics, diagnosis, treatment options, … , et al. Advanced lung cancer inflammation index combined with … . Identification of metabolic genes for the prediction of …
About
© 1995-2025